Volume 16, Issue 3 pp. 266-274

Propofol anesthesia in spontaneously breathing children undergoing magnetic resonance imaging: comparison of two propofol emulsions

ANTON GUTMANN MD

ANTON GUTMANN MD

Department of Anaesthesiology and Intensive Care Medicine, Medical University Graz, Graz, Austria

Search for more papers by this author
KLAUS PESSENBACHER MD

KLAUS PESSENBACHER MD

Department of Anaesthesiology and Intensive Care, General Hospital Muerzzuschlag-Mariazell, Austria

Search for more papers by this author
ANDREA GSCHANES PhD

ANDREA GSCHANES PhD

CIS-Services, Graz, Austria

Search for more papers by this author
UDO EGGENREICH PhD

UDO EGGENREICH PhD

CIS-Services, Graz, Austria

Search for more papers by this author
MANFRED WARGENAU PhD

MANFRED WARGENAU PhD

MARCO Institute for Clinical Research and Statistics, Duesseldorf, Germany

Search for more papers by this author
WOLFGANG TOLLER MD

WOLFGANG TOLLER MD

Department of Anaesthesiology and Intensive Care Medicine, Medical University Graz, Graz, Austria

Search for more papers by this author
First published: 29 November 2005
Citations: 12
A. Gutmann, Department of Anaesthesiology and Intensive Care Medicine, Medical University Graz, Auenbruggerplatz 29, A-8036 Graz, Austria (email: [email protected]).

Summary

Background: This study evaluated a propofol-based anesthesia regimen with spontaneous breathing in pediatric patients scheduled for magnetic resonance imaging (MRI).

Methods: In this prospective, randomized, double-blind study propofol formulated with long-chain triglycerides (LCT) and mixed medium-chain/long-chain triglycerides (MCT/LCT) were used. Ninety patients aged 2.4 months to 7.3 years were premedicated with intravenous midazolam. Lidocaine was injected prior to propofol to reduce injection pain. Anesthesia was induced and maintained by propofol. Glycopyrronium bromide was administered for saliva reduction. Hemodynamics, blood oxygen saturation and endtidal capnography were continuously monitored. All patients received additional oxygen. The aggregated propofol dose for induction and maintenance of anesthesia was analyzed for therapeutic equivalence. Incidence of injection pain, laboratory safety values, vital signs, and the adverse event profile were analyzed to compare tolerability and safety.

Results: Propofol anesthesia was safe and successful in all children. Both propofol formulations were equivalent regarding dose requirements (mean induction and maintenance doses for anesthesia 2.0–4.0 mg·kg−1 and 6.0–8.8 mg·kg−1·h−1 respectively; aggregated doses 8–13.26 mg·kg−1). There were no differences in drug safety such as hemodynamics, spontaneous breathing, injection pain, and laboratory values. Duration of induction and of recovery from anesthesia were short and all examinations were completed with minimal interruption.

Conclusions: Propofol-based short-term anesthesia was well suited for anesthesia during MRI procedures in the studied pediatric patients. There were no clinically relevant differences between the two propofol formulations.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.